United States Antimony (UAMY) is back on investors’ radar after recent trading highlighted sharp share price moves, alongside mixed return figures that include gains year to date but declines over the past month and over the past 3 months.

Recent trading in United States Antimony has been choppy, with a 1-day share price return of down 10.13% to $7.01 and a 30-day share price return of down 16.75%. At the same time, the year to date share price return remains up 18.21% and the 1-year total shareholder return is 171.71%. This suggests longer term momentum has been strong while shorter term momentum is fading as investors reassess the balance between growth potential and risk.

If movements in United States Antimony have you looking more widely at materials exposure, this could be a useful moment to review rare earth peers using our 29 best rare earth metal stocks

With United States Antimony showing strong 1 year and 3 year total returns but still trading well below the average analyst price target, investors are left asking whether the stock is undervalued or if the market already prices in future growth.

Most Popular Narrative: 46.3% Undervalued

On the latest numbers, the most followed narrative places United States Antimony's fair value at $13.06, compared with a last close of $7.01. This framing highlights a significant valuation gap built around growth and capacity assumptions.

US Antimony is expanding its domestic processing capacity (for example, a sixfold increase at the Thompson Falls facility expected by year-end) and increasing ore supply both from its own Montana/Alaska projects and multiple new international sources. This is expected to drive higher production volumes and sustained revenue growth through increased throughput and supply security.

Curious what revenue ramp, margin shift, and earnings path are baked into that fair value for United States Antimony? The core narrative leans on rapid top line expansion, a sharp swing from losses to profits, and a richer future earnings multiple. The exact mix of growth, profitability, and valuation assumptions may surprise you.

Result: Fair Value of $13.06 (UNDERVALUED)

However, United States Antimony still faces real swing factors, including permitting setbacks at key projects and the risk that modeled profit margins do not match actual operating performance.

Another View on United States Antimony’s Valuation

The analyst narrative leans on future earnings and a higher P/E in 2029, but the current P/S ratio of 26.5x tells a very different story. It sits far above the US Metals and Mining industry at 2.6x, peers at 6.3x, and even the 5.8x fair ratio estimate. This points to meaningful valuation risk if expectations cool.

To see how those revenue and margin assumptions line up with the current pricing, and what the fair ratio suggests the market could move toward, take a closer look at the valuation breakdown using our See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed sentiment around United States Antimony, do you see more risk or more upside here, and how soon do you want answers? Put the numbers in context for yourself by weighing up the 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond United States Antimony?

If United States Antimony has sharpened your focus, do not stop here; broaden your watchlist and pressure test your thinking across different types of opportunities.

• Target potential income anchors by scanning companies we flag as reliable payers through the 7 dividend fortresses.
• Surface potential mispriced opportunities with healthy fundamentals by running your criteria through the 44 high quality undervalued stocks.
• Prioritize resilience by reviewing companies that score well for stability via the 67 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.